About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Twitter List
Legislative Tracking Tools
Monthly Archives: December 2013
Weekly Roundup 12-20-13
Yes, I did it. Cards addressed and sent. Gifts purchased, wrapped and sent. The snow in my snow globe descends quietly and peacefully conveying my own inner serenity…. And here is a little of what happened this week, as 2013 … Continue reading
Posted in Uncategorized
Comments Off on Weekly Roundup 12-20-13
Optimizing for Mobile – Do It!
Recently a research report by Manhattan Research found that only about a third of pharma web sites have been optimized for mobile use. While I still know people who do not have a smart phone, there aren’t many of them. … Continue reading
Posted in Uncategorized
Comments Off on Optimizing for Mobile – Do It!
Weekly Roundup – 12-13-13
Ho Ho Ho. Sort of. Gifts not yet bought, much less wrapped. In fact, ideas for buying gifts seem not to be forthcoming. Cards sitting in their boxes without addresses or messages written inside. Crowded stores. No parking. Traffic. It … Continue reading
Posted in Uncategorized
Comments Off on Weekly Roundup – 12-13-13
Abandoned Properties – Social Media and Pharma
Every so often, one sees an article about what happens to the social media identities of people who have passed away. But what happens when a social media asset is abandoned – abandoned by a brand? Keeping track of social … Continue reading
Posted in Social Media
Comments Off on Abandoned Properties – Social Media and Pharma
Risky Business – Risk Information and Promotion
In my data base of Office of Prescription Drug Promotion (OPDP) Warning and Untitled Letters issued during the years 2004-2013, one of the many fields I track is, of course, the type of violations that were incurred. There are many, … Continue reading
Posted in Warning Letters
Comments Off on Risky Business – Risk Information and Promotion